The latest research, news, and more from GeoInvesting for Navidea Biopharmaceuticals, Inc (NAVB) /companies/navb_navidea_biopharmaceuticals__inc/overview en-us Tue, 14 Apr 2026 16:42:36 GMT Tue, 14 Apr 2026 16:42:36 GMT 120 36828Thu, 15 Nov 2012 05:00:00 GMTNavidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents. Navidea is actively developing four radiopharmaceutical agent platforms - Lymphoseek(R), NAV4694, NAV5001 (CFT) and RIGScan(TM) - to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making and, ultimately, patient care. Navidea's strategy is to deliver superior growth and shareholder return by bringing to market novel radiopharmaceutical agents and advancing the Company's pipeline through selective acquisitions, global partnering and commercialization efforts. For more information, please visit <A href="http://www.navidea.com">www.navidea.com</A>./companies/navb_navidea_biopharmaceuticals__inc/overview